Podcast
Questions and Answers
Why is tirzepatide contraindicated in patients with a history of pancreatitis?
Why is tirzepatide contraindicated in patients with a history of pancreatitis?
- The weight loss associated with tirzepatide leads to rapid fat mobilization, elevating serum triglyceride levels and precipitating pancreatitis in susceptible individuals.
- Tirzepatide directly damages the pancreatic acinar cells, exacerbating existing damage.
- Tirzepatide induces an autoimmune response targeting the pancreas due to its molecular structure resembling pancreatic antigens.
- The drug's mechanism of action includes slowing gastric emptying, which increases pancreatic enzyme secretion and, consequently, the risk of inflammation in individuals susceptible to pancreatic issues. (correct)
How does tirzepatide's mechanism of action primarily contribute to its antidiabetic effect?
How does tirzepatide's mechanism of action primarily contribute to its antidiabetic effect?
- Via glucose-dependent insulin secretion, which reduces the risk of hypoglycemia compared to insulin secretagogues that are glucose-independent. (correct)
- Through the direct stimulation of insulin release from pancreatic beta cells, irrespective of glucose levels, leading to a reduction in blood sugar.
- By selectively blocking the reabsorption of glucose in the proximal renal tubules, resulting in increased glucose excretion.
- By inhibiting hepatic glucose production through the suppression of key gluconeogenic enzymes.
Which statement best describes the advantage of using tirzepatide in combination with metformin for T2DM?
Which statement best describes the advantage of using tirzepatide in combination with metformin for T2DM?
- The combination allows for increased absorption of metformin in the gastrointestinal tract.
- The combination mitigates the risk of lactic acidosis associated with metformin monotherapy.
- Combining tirzepatide with metformin exclusively targets postprandial hyperglycemia.
- Combining the medications addresses complementary mechanisms, decreasing insulin resistance and increasing insulin secretion. (correct)
What is the significance of tirzepatide being administered via subcutaneous injection?
What is the significance of tirzepatide being administered via subcutaneous injection?
What is a key consideration when initiating tirzepatide therapy in a patient already on other antidiabetic medications?
What is a key consideration when initiating tirzepatide therapy in a patient already on other antidiabetic medications?
How does tirzepatide-induced weight loss potentially contribute to improved glycemic control in patients with T2DM?
How does tirzepatide-induced weight loss potentially contribute to improved glycemic control in patients with T2DM?
A patient taking tirzepatide reports persistent nausea. What is the most appropriate initial intervention?
A patient taking tirzepatide reports persistent nausea. What is the most appropriate initial intervention?
How does tirzepatide affect gastric emptying and what implication does this have for patients taking oral medications?
How does tirzepatide affect gastric emptying and what implication does this have for patients taking oral medications?
Which patient population would require the most cautious monitoring when prescribed tirzepatide, given its mechanism of action?
Which patient population would require the most cautious monitoring when prescribed tirzepatide, given its mechanism of action?
What is the rationale behind administering tirzepatide once weekly rather than daily or multiple times per day?
What is the rationale behind administering tirzepatide once weekly rather than daily or multiple times per day?
Flashcards
Tirzepatide
Tirzepatide
A once-weekly injectable medication that can be used alone or with other diabetic medications.
Tirzepatide MOA
Tirzepatide MOA
Enhances glucose-dependent insulin secretion, slows gastric emptying, and increases satiety.
Tirzepatide indication
Tirzepatide indication
Primarily indicated for the treatment of Type 2 Diabetes Mellitus.
Tirzepatide contraindication
Tirzepatide contraindication
Signup and view all the flashcards
Tirzepatide Side effect
Tirzepatide Side effect
Signup and view all the flashcards
Study Notes
- Tirzepatide is a GLP-1 agonist.
- Administered once weekly via subcutaneous injection using an autoinjector pen.
- Can be prescribed as a monotherapy or with other diabetes medications, like Metformin or SGLT2 inhibitors.
Mechanism of Action
- Increases GLP-1, which enhances glucose-dependent insulin secretion.
- Slows gastric emptying.
- Increases satiety.
Indications
- Indicated for the treatment of type 2 diabetes mellitus (T2DM).
Contraindications
- Contraindicated in patients with a history of pancreatitis.
Side Effects
- May cause pancreatitis.
- May cause weight loss.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.